CAREDX, INC. Marketable Securities, Unrealized Gain (Loss)
CAREDX, INC. (CDNA) reported Marketable Securities, Unrealized Gain (Loss) of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2025-02-28
- CAREDX, INC. marketable securities, unrealized gain (loss) for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- CAREDX, INC. marketable securities, unrealized gain (loss) for the quarter ending 2024-09-30 was $0.00.
- CAREDX, INC. marketable securities, unrealized gain (loss) for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- CAREDX, INC. marketable securities, unrealized gain (loss) for the quarter ending 2024-03-31 was $0.00.
- CAREDX, INC. marketable securities, unrealized gain (loss) for fiscal 2024 was $0.00.
- CAREDX, INC. marketable securities, unrealized gain (loss) for fiscal 2023 was $0.00.
- CAREDX, INC. marketable securities, unrealized gain (loss) for fiscal 2022 was -$1.18M.
- CAREDX, INC. marketable securities, unrealized gain (loss) for fiscal 2021 was -$1.74M.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $0.00 derived: sum of 2 quarters · filed 2024-11-04 | $0.00 10-Q · filed 2024-11-04 | $1.19M derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $0.00 10-Q · filed 2024-07-31 | $1.19M derived: sum of 3 quarters · filed 2025-02-28 | $852.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $1.19M derived: sum of 2 quarters · filed 2025-02-28 | $852.00K derived: sum of 3 quarters · filed 2025-02-28 | $905.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $852.00K derived: sum of 2 quarters · filed 2025-02-28 | $905.00K derived: sum of 3 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 |
| 2023-09-30 | -$333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$280.00K derived: sum of 2 quarters · filed 2024-11-04 | -$1.19M 10-Q · filed 2024-11-04 | -$2.15M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$852.00K 10-Q · filed 2024-07-31 | -$1.82M derived: sum of 3 quarters · filed 2025-02-28 | -$1.55M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$905.00K 10-Q · filed 2024-05-09 | -$1.87M derived: sum of 2 quarters · filed 2025-02-28 | -$1.60M derived: sum of 3 quarters · filed 2025-02-28 | -$1.58M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$966.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$695.00K derived: sum of 2 quarters · filed 2025-02-28 | -$674.00K derived: sum of 3 quarters · filed 2025-02-28 | -$1.18M 10-K · filed 2025-02-28 |
| 2022-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $292.00K derived: sum of 2 quarters · filed 2023-11-08 | -$215.00K 10-Q · filed 2023-11-08 | -$1.79M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$486.00K 10-Q · filed 2023-08-08 | -$2.06M derived: sum of 3 quarters · filed 2024-02-28 | -$5.32M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$507.00K 10-Q · filed 2023-05-10 | -$2.08M derived: sum of 2 quarters · filed 2024-02-28 | -$5.34M derived: sum of 3 quarters · filed 2024-02-28 | -$2.25M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$4.83M derived: sum of 2 quarters · filed 2024-02-28 | -$1.74M derived: sum of 3 quarters · filed 2024-02-28 | -$1.74M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$3.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$167.00K derived: sum of 2 quarters · filed 2022-11-03 | -$167.00K 10-Q · filed 2022-11-03 | -$167.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $3.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.09M 10-Q · filed 2022-08-04 | $3.09M derived: sum of 3 quarters · filed 2023-02-27 | $3.09M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $0.00 10-K · filed 2023-02-27 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $0.00 10-Q · filed 2021-10-28 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-07-29 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |